INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE

THE TEMPUS SEQUENCING LAB

Tempus is CAP accredited and licensed under the Clinical Laboratory Improvement Amendment of 1988 (“CLIA”) and is authorized to provide diagnostic laboratory services in the states of Illinois, Georgia, and North Carolina. Our highly robotic laboratories are optimized for high throughput clinical next-generation sequencing.

Chicago—Tempus Headquarters and Lab

600 West Chicago Avenue
Suite 510
Chicago, IL 60654

  • xT Solid Tumor + Normal Match 648 gene panel by DNA sequencing
  • xR Whole transcriptome RNA sequencing panel
  • xF/xF+ Liquid Biopsy 105/523 gene cfDNA sequencing panel
  • xE Whole Exome 19,000+ gene DNA sequencing panel
  • xG/xG+ Germline (passed through to Ambry Genetics®) 36/77) 52/88 gene DNA sequencing panel for hereditary cancers
  • Algorithmic Tests: TO, HRD, DPYD, UGT1A1, PurISTSM
  • IHC: MMR, PD-L1 (22C3, 28-8, SP142, SP263)
Licenses: CAP, CLIA, NYS

Atlanta—Tempus Lab

3100 Northwoods Place
Peachtree Corners, GA 30071

3155 Northwoods Place, Norcross, GA 30071

  • CytoSNP
  • nP
Licenses: CAP, CLIA, NYS

Durham—Tempus Lab

25 Alexandria Way
Suite 300
Durham, NC 27703

  • xT Solid Tumor + Normal Match 648 gene panel by DNA sequencing
  • xR Whole transcriptome RNA sequencing panel
  • Algorithmic Tests: TO, HRD, DPYD, UGT1A1, PurISTSM
  • IHC: MMR, PD-L1 (22C3, 28-8, SP142, SP263)
Licenses: CAP, CLIA, NYS
image description

Our state-of-the-art, CAP accredited, and CLIA certified lab

Download our lab overview

This is data-driven precision medicine

This is the future of healthcare.